Institute of Basic Medical Sciences

Established in 1978, the Institute of Basic Medical Sciences (IBMS) of the Chinese Academy of Medical Sciences (CAMS) also serves as the School of Basic Medicine for Peking Union Medical College (PUMC). IBMS was formed by merging the Institute of Experimental Medicine of CAMS (founded in 1958) and the basic medical science departments of PUMC (founded in 1921). Devoted to excellence in both biomedical research and advanced medical education, IBMS now consists of 13 academic departments, a National Key Laboratory of Medical Molecular Biology, a National Platform of Experimental Cell Resources, and a National Basic Medical Experimental Teaching Center, with a faculty of 126 full or associate professors including three members of the Chinese Academy of Sciences and three members of the Chinese Academy of Engineering.


alt phone

The scientific research programs at IBMS are focused on basic and translational medical research in fields including functional genomics, epigenetics, proteomics, molecular immunology, and human molecular genetics. Using the approaches of integrated systems biology, research efforts aim to study diseases at the molecular, cellular, tissue, organ, and individual level, and to provide the scientific basis for novel strategies in the early detection, prevention, and treatment of major diseases in China.

Since the start of the 11th five-year plan (2006–2010), more than 100 research projects at IBMS have been sponsored by national scientific research funding programs. Faculty from IBMS have published more than 1,800 papers in leading international scientific journals.

IBMS has recently made remarkable progresses in multiple projects involving research on and development of diagnostic assays, genetically engineered drugs, traditional Chinese medicine, and biomedical polymers, and has established collaborations with more than 20 pharmaceutical companies in China and abroad. Since 2006, IBMS has been granted 69 patents. Currently there is one clinical trial in progress. IBMS also plays an essential role in medical education at PUMC.
With the support from the Ministry of Science and Technology and the Health and Family Planning Commission (NHFPC), IBMS has established a series of state-of-the-art research centers. The Core Instrument Facility is equipped with the most advanced scientific instruments, as well as expertise in their applications, to serve the research community inside and outside the institute. The Cell Resource Center, accredited as a national research hub since 2011, offers a broad spectrum of cell line products and cell culture services for biomedical research. The newly renovated Experimental Animal Center is a specific pathogen-free-certified animal laboratory equipped with advanced animal research tools and capabilities. The Histopathology Core Facility was recently established to promote translational medical research. IBMS also has the Proteomics Center, the Tissue Engineering Center, the Nanomedicine Center, the Center for Systems Medicine, the McKusick-Zhang Center for Genetic Medicine, the Center for Neuroscience, the Center for Bioethics of CAMS, the Center for Medical Primate Animals, and the Immunotherapy Center.

IBMS aims to become a world-class institute and achieve excellence in biomedical research and advanced medical education. To that end, the institute has established long-term development plans and implemented a series of initiatives to facilitate innovation, integration, and efficiency. The faculty and staff members are encouraged to participate in institutional management. The Academic Committee, the Education Committee, and the Developmental Committee all play active roles in decision-making.